In vitro and in vivo interactions between nuclear receptors at estrogen response elements

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 5-6, 1996, Pages 507-515

  Joyeux, A ^a   Balaguer, P ^a   Gagne, D ^a   Nicolas, J C ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

CALCITRIOL RECEPTOR; CELL RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; RETINOIC ACID RECEPTOR;

ANIMAL; ARTICLE; METABOLISM; SACCHAROMYCES CEREVISIAE;

ANIMALS; ESTROGENS; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; SACCHAROMYCES CEREVISIAE;

EID: 0030202557     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00082-9     Document Type: Article

References (33)

1. Evans R. M.: The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895.
2. Beato M.: Gene regulation by steroid hormones. Cell 56 (1989) 325-344.
3. Gronemeyer H.: Control of transcription activation by steroid hormone receptors. FASEB J. 6 (1992) 2524-2529.
4. Tsai M. J. and O'Malley B. W.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486.
5. Giguère V.: Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev. 15 (1994) 61-79.
6. Schräder M., Bendik I., Becker-André M. and Carlberg C.: Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem. 268 (1993) 17830-17836.
7. Schräder M., Müller K. M. and Carlberg C.: Specificity and flexibility of vitamin D signaling. J. Biol. Chem. 269 (1994) 5501-5504.
8. Demirpence E., Pons M., Balaguer P. and Gagne D.: Study of an antiestrogenic effect of retinoic acid in MCF7 cells. Biochem. Biophys. Res. Commun. 183 (1992) 100-106.
9. Demirpence E., Balaguer P., Trousse F., Nicolas J. C., Pons M. and Gagne D.: Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res. 54 (1994) 1458-1464.
10. Savouret J. F., Rauch M., Redeuilh G., Sar S., Chauchereau A., Woodruff K., Parker M. G. and Milgrom E.: Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J. Biol. Chem. 269 (1994) 28955-28962.
11. Koga M. and Sutherland R. L.: Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Molec. Biol. 39 (1991) 455-460.
12. Fontana J. A., Nervi C., Shao Z. M. and Jetten A. M.: Retinoid antagonism of estrogen-responsive transforming growth factor a and pS2 gene expression in breast carcinoma cells. Cancer Res. 52 (1992) 3938-3945.
13. Glass C. K., Holloway J. M., Devary O. V. and Rosenfeld M. G.: The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54 (1988) 313-323.
14. Keller H., Givel F., Perroud M. and Wahli W.: Signaling cross-talk between peroxisome proliferator-activated receptor/ retinoid X receptor and estrogen receptor through estrogen response elements. Molec. Endocr. 9 (1995) 794-804.
15. Bostein D. and Fink G. R.: Yeast: an experimental organism for modern biology. Science 240 (1988) 1439-1443.
16. Heery D. M., Pierrat B., Gronemeyer H., Chambon P. and Losson R.: Homo- and heterodimers of the retinoid X receptor (RXR) activate transcription in yeast. Nucl. Acids Res. 22 (1994) 726-731.
17. Metzger D., White J. H. and Chambon P.: The human oestrogen receptor functions in yeast. Nature 334 (1988) 31-36.
18. Pierrat B., Heery D. M., Lemoine Y. and Losson R.: Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast. Gene 119 (1992) 237-245.
19. Wright A. P. H., Carlstedt-Duke J. and Gustafsson J. A.: Ligand-specific transactivation of gene expression by a derivative of the human glucocorticoid receptor expressed in yeast. J. Biol. Chem. 265 (1990) 14763-14769.
20. Heery D. M., Zacharewski T., Pierrat B., Gronemeyer H., Chambon P. and Losson R.: Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors. Proc. natn. Acad. Sci. U.S.A. 90 (1993) 4281-4285.
21. Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M. and Thaller C.: 9-cis retinoic acid is a high affinity ligand for the retinoid receptor. Cell 68 (1992) 397-406.
22. Bagchi M. K., Tsai M. J. and O'Malley B. W.: Purification and characterization of chicken ovalbumin gene upstream promoter transcription factor from homologous oviduct cells. Molec. Cell. Biol. 7 (1987) 4151-4158.
23. Lee M. O., Liu Y. and Zhang X. K.: A retinoic response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. Molec. Cell. Biol. 15 (1995) 4194-4207.
24. McDonnell D. P., Nawaz Z. and O'Malley B. W.: In situ distinction between steroid receptor binding and transactivation at a target gene. Molec. Cell. Biol. 11 (1991) 4350-4355.
25. vom Baur E., Zechel C., Heery D., Heine M. J. S., Gamier J. M., Viviat V., Le Douarin B., Gronemeyer H., Chambon P. Losson R.: Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15 (1996) 110-124.
26. Lee J. W., Choi H. S., Gyuris J., Brent R. and Moore D. D.: Two classes of proteins dependent of either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Molec. Endocr. 9 (1995) 243-254.
27. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A. and Moore D. D.: Interaction of a thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374 (1995) 91-94.
28. Mader S., Leroy P., Chen J. Y. and Chambon P.: Multiple parameters control the selectivity of nuclear receptors for their response elements - selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid-X receptors. J. Biol. Chem. 268 (1993) 591-600.
29. Ince B. A., Zhuang Y., Wrenn C. K., Shapiro D. J. and Katzenellenbogen B. S.: Powerful dominant negative mutants of the human estrogen receptor. J. Biol. Chem. 268 (1993) 14026-14032.
30. Cavaillès V., Dauvois S., Danielian P. S. and Parker M. G.: Interaction of proteins with transcriptionally active estrogen receptors. Proc. natn. Acad. Sci. U.S.A. 91 (1994) 10009-10013.
31. Cavaillès V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J. and Parker M. G.: Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751.
32. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C. and Brown M.: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458.
33. Le Douarin B., Zechel C., Garnier J. M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P. and Losson R.: The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic prtein T18. EMBO J. 14 (1995) 2020-2033.